Related Experiment Video
Updated: Jul 6, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Hemophilia--present and past]
1Showa University.
Through a research of existing literature, the clinical manifestion, diagnosis and treatment of hemophilia A and B are described. This article reviews the recent progress of coagulation factor VIII and IX products, and the efficiency of bypass therapy with rFVIIa, etc., to induce immune tolerance induction in congenital hemophilia with inhibitors and acquired hemophilia. In the future, an explanation of the mechanism and prophylaxy of inhibitors and the progress of genetic therapy are expected.
Through a research of existing literature, the clinical manifestion, diagnosis and treatment of hemophilia A and B are described. This article reviews the recent progress of coagulation factor VIII and IX products, and the efficiency of bypass therapy with rFVIIa, etc., to induce immune tolerance induction in congenital hemophilia with inhibitors and acquired hemophilia. In the future, an explanation of the mechanism and prophylaxy of inhibitors and the progress of genetic therapy are expected.
More Related Videos
09:35Constitutive and Inducible Systems for Genetic In Vivo Modification of Mouse Hepatocytes Using Hydrodynamic Tail Vein Injection
Published on: February 2, 2018
08:01The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
Published on: February 27, 2026
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemorrhagic Stroke l: Introduction